Ontology highlight
ABSTRACT:
SUBMITTER: Flamm S
PROVIDER: S-EPMC7379735 | biostudies-literature | 2019 Mar
REPOSITORIES: biostudies-literature
Flamm Steven S Mutimer David D Asatryan Armen A Wang Stanley S Rockstroh Jürgen J Horsmans Yves Y Kwo Paul Y PY Weiland Ola O Villa Erica E Heo Jeong J Gane Edward E Ryder Stephen D SD Welzel Tania M TM Ruane Peter J PJ Agarwal Kosh K Ng Teresa I TI Xue Zhenyi Z Lovell Sandra S SS Krishnan Preethi P Kopecky-Bromberg Sarah S Trinh Roger R Mensa Federico J FJ Wyles David L DL
Journal of viral hepatitis 20181211 3
Glecaprevir coformulated with pibrentasvir (G/P) is approved to treat hepatitis C virus (HCV) infection and was highly efficacious in phase 2 and 3 studies. Treating HCV genotype (GT) 3 infection remains a priority, as these patients are harder to cure and at a greater risk for liver steatosis, fibrosis progression and hepatocellular carcinoma. Data were pooled from five phase 2 or 3 trials that evaluated 8-, 12- and 16-week G/P in patients with chronic HCV GT3 infection. Patients without cirrho ...[more]